Untitled

HealthTrust presents...”Debate of the DOACs: A Comparison of Generic Dabigatran vs. Rivaroxaban & Apixaban”

Clinical trials have proven the superiority of generic dabigatran in comparison to warfarin in significantly reducing ischemic and hemorrhagic strokes. Other studies comparing the efficacy of dabigatran to other direct oral anticoagulants (DOACs) (i.e., apixaban and rivaroxaban) have suggested equivalency as well. In clinical practice, the use of DOACs have increased as they have been statistically and clinically proven effective in preventing and treating thromboembolic events. While these agents are beneficial in several cardiovascular disease states, some are associated with a greater cost burden than others. Although apixaban and rivaroxaban are more commonly prescribed, recent studies comparing these agents to dabigatran have shown similar effectiveness in preventing thromboembolic events. In this session, the clinical indications for each will be outlined and cases in which substitution is appropriate will be assessed.

Learning Objectives for Pharmacists & Nurses  |  At the end of this session, participants should be able to:

1. Recall current evidence-based guidelines that assess the clinical indications and effectiveness for dabigatran, apixaban and rivaroxaban
2. Identify financial consideration in the use of dabigatran, apixaban, and rivaroxaban
3. Recognize cases in which generic dabigatran may be an appropriate substitution for apixaban and rivaroxaban

Presenter:

Jana Kelly, PharmD  |  PGY-1 Pharmacy Resident  |  McLeod Health

Target Audience: Pharmacists, Nurses &  Physicians

CE Credit: Approved for Pharmacists & Nurses

This program is approved for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this activity is 0863-9999-24-067-L01-P. The activity is approved for Pharmacists & Nurses for 1 hour (.1 CEUs) of continuing education credit for those who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.

Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.